サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1338910

エリスロポエチン製剤市場、シェア、規模、動向、産業分析レポート：製品別、タイプ別、用途別、地域別、セグメント別予測、2023年～2032年

Erythropoietin Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Biologics & Biosimilars); By Product (Erythropoietin, Darbepoetin-alfa); By Application; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
エリスロポエチン製剤市場、シェア、規模、動向、産業分析レポート：製品別、タイプ別、用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のエリスロポエチン製剤市場規模は2032年までに76億5,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

貧血は世界的に主要な健康問題であり、エリスロポエチン製剤はその主な治療薬です。米国CDCの慢性腎臓病によると、米国では成人の15％、3,700万人がCKDに罹患していると推定されています。CKDは、45～64歳（13％）、18～44歳（7％）よりも高齢者に多いです。さらに、先発医薬品に代わる安価なバイオシミラーの需要増が、エリスロポエチン製剤の必要性を高めると予想されています。

エリスロポエチン製剤の採用は、他の地域に比べて北米で多いです。これは、貧血や慢性腎臓病の有病率が高いこと、高度なヘルスケア・インフラが整備されていること、大手製薬会社が多数進出していることなど、いくつかの要因によるものです。

さらに、有利な政府の政策や償還制度も、北米におけるエリスロポエチン製剤の普及に寄与しています。例えば米国では、メディケアが末期腎疾患患者に対してエリスロポエチン療法を保険適用しており、これにより同国の患者のエリスロポエチン製剤へのアクセスが大幅に向上しています。

ご質問はありますか？本レポートを購入される前に、サンプルのご請求やお問い合わせをされますか？

2023年2月、GSKが製造するジェスデュブローク錠は、慢性腎臓病による貧血を患い、4カ月以上透析を受けている成人に対する初の経口治療薬として米国食品医薬品局から承認を取得しました。この承認は、これまでエリスロポエチン注射剤に頼らざるを得なかった患者にとって、より簡便でアクセスしやすい治療選択肢を提供するものであり、慢性腎臓病による貧血治療における大きなブレークスルーとなります。

2022年11月、英国の国民保健サービスは、ドナー細胞から培養した赤血球の輸血を世界で初めて実施し、画期的な成果を収めました。この科学的なマイルストーンは、希少な血液型を持つ人々の治療に新たな道を開く可能性があります。

エリスロポエチン製剤市場レポートハイライト

生物製剤部門が市場を独占し、収益の大きなシェアを占めています。人気製品にはプロクリット、ネオレコルモン、エポジン、ミルセラ、アラネスプ、エポゲンなどがあります。

2022年にはエリスロポエチン・セグメントが最大の市場シェアを占める。エポエチン-ベータは、エポエチン-アルファよりも血液透析患者のヘモグロビン濃度維持に優れているため、将来的にプラス成長が見込まれます。

2022年には、腎移植や関連疾患に対する償還政策の発展もこの分野を牽引しているため、腎疾患分野が市場で最大のシェアを占める。

北米は、医薬品開拓を進める組織の存在、CKD患者に対するメディケアの適用、エポゲン、アラネスプ、プロクリットなどの薬剤のFDA承認などにより、市場を独占し、予測期間中に最も高いCAGRで成長すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のエリスロポエチン製剤市場に関する洞察

  • エリスロポエチン製剤市場- 製品スナップショット
  • エリスロポエチン製剤市場力学
    • 促進要因と機会
      • 慢性疾患の発生率の増加
      • 赤血球生成刺激薬（ESA）の適応外使用
    • 抑制要因と課題
      • ブランド医薬品の特許満了
  • PESTEL分析
  • エリスロポエチン製剤市場の製品動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のエリスロポエチン製剤市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 生物製剤
  • バイオシミラー

第6章 世界のエリスロポエチン製剤市場、用途別

  • 主な調査結果
  • イントロダクション
  • がん
  • 腎臓病
  • 神経内科
  • その他

第7章 世界のエリスロポエチン製剤市場、製品別

  • 主な調査結果
  • イントロダクション
  • エリスロポエチン
  • ダルベポエチンアルファ

第8章 世界のエリスロポエチン製剤市場、地域別

  • 主な調査結果
  • イントロダクション
    • エリスロポエチン製剤市場評価、地域別、2019～2032年
  • エリスロポエチン製剤市場-北米
    • 北米：エリスロポエチン製剤市場、タイプ別、2019～2032年
    • 北米：エリスロポエチン製剤市場、製品別、2019～2032年
    • 北米：エリスロポエチン製剤市場、用途別、2019～2032年
    • エリスロポエチン製剤市場-米国
    • エリスロポエチン製剤市場- カナダ
  • エリスロポエチン製剤市場- 欧州
    • 欧州：エリスロポエチン製剤市場、タイプ別、2019～2032年
    • 欧州：エリスロポエチン製剤市場、製品別、2019～2032年
    • 欧州：エリスロポエチン製剤市場、用途別、2019～2032年
    • エリスロポエチン製剤市場- 英国
    • エリスロポエチン製剤市場- フランス
    • エリスロポエチン製剤市場- ドイツ
    • エリスロポエチン製剤市場- イタリア
    • エリスロポエチン製剤市場- スペイン
    • エリスロポエチン製剤市場- オランダ
    • エリスロポエチン製剤市場- ロシア
  • エリスロポエチン製剤市場- アジア太平洋
    • アジア太平洋：エリスロポエチン製剤市場、タイプ別、2019～2032年
    • アジア太平洋：エリスロポエチン製剤市場、製品別、2019～2032年
    • アジア太平洋：エリスロポエチン製剤市場、用途別、2019～2032年
    • エリスロポエチン製剤市場- 中国
    • エリスロポエチン製剤市場- インド
    • エリスロポエチン製剤市場- マレーシア
    • エリスロポエチン製剤市場- 日本
    • エリスロポエチン製剤市場- インドネシア
    • エリスロポエチン製剤市場- 韓国
  • エリスロポエチン製剤市場-中東およびアフリカ
    • 中東およびアフリカ：エリスロポエチン製剤市場、タイプ別、2019～2032年
    • 中東およびアフリカ：エリスロポエチン製剤市場、製品別、2019～2032年
    • 中東およびアフリカ：エリスロポエチン製剤市場、用途別、2019～2032年
    • エリスロポエチン製剤市場- サウジアラビア
    • エリスロポエチン製剤市場- アラブ首長国連邦
    • エリスロポエチン製剤市場- イスラエル
    • エリスロポエチン製剤市場- 南アフリカ
  • エリスロポエチン製剤市場-ラテンアメリカ
    • ラテンアメリカ：エリスロポエチン製剤市場、タイプ別、2019～2032年
    • ラテンアメリカ：エリスロポエチン製剤市場、製品別、2019～2032年
    • ラテンアメリカ：エリスロポエチン製剤市場、用途別、2019～2032年
    • エリスロポエチン製剤市場- メキシコ
    • エリスロポエチン製剤市場- ブラジル
    • エリスロポエチン製剤市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Amgen
  • Johnson & Johnson
  • Roche Ltd
  • Pfizer
  • Biocon
  • Teva Pharmaceutical
  • Kyowa Kirin
  • LG Life Sciences
  • AstraZeneca
  • Intas Pharmaceuticals
  • Shire
  • Sanofi
  • Novartis
  • Boehringer Ingelheim
  • Baxter International Inc.
図表

List of Tables

  • Table 1 Global Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 4 Erythropoietin Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 8 U.S.: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Canada: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 14 Europe: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 17 UK: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 20 France: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Germany: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Italy: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 29 Spain: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Russia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 41 China: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 44 India: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Japan: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 56 South Korea: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 65 UAE: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Israel: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 71 South Africa: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 74 Latin America: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 77 Mexico: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 80 Brazil: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • Table 83 Argentina: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Erythropoietin Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Erythropoietin Drugs Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Erythropoietin Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Product
  • Figure 11. Global Erythropoietin Drugs Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 12. Erythropoietin Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Erythropoietin Drugs Market
目次
Product Code: PM3354

The global erythropoietin drugs market size is expected to reach USD 7.65 billion by 2032, according to a new study by Polaris Market Research. The report "Erythropoietin Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Biologics & Biosimilars); By Product (Erythropoietin, Darbepoetin-alfa); By Application; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Anemia is a major health concern globally, and Erythropoietin Drugs are the primary treatment for the condition. According to the CDC chronic kidney disease in the United States, 15% of adults in the USA, or 37 million people are estimated to have CKD. It is more common in old age population than in people aged 45-64 years (13%) and 18-44 years (7%). Moreover, the increasing demand for biosimilars, which are cheaper alternatives to branded drugs, is expected to drive the need for Erythropoietin Drugs.

Adoption of erythropoietin drugs is greater in North America compared to other regions. This is due to several factors such as the high prevalence of anemia and chronic kidney disease, the availability of advanced healthcare infrastructure, and the presence of a large number of major pharmaceutical companies in the region.

Additionally, favorable government policies and reimbursement schemes have also contributed to the widespread adoption of erythropoietin drugs in North America. For example, in the United States, Medicare provides coverage for erythropoietin therapy for patients with end-stage renal disease, which has significantly increased access to these drugs for patients in the country.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report?

In February 2023, Jesduvroq tablets, manufactured by GSK, received approval from the U.S. Food and Drug Administration as the first oral treatment option for adults suffering from anaemia due to chronic kidney disease and who have undergone dialysis for at least four months. This approval represents a significant breakthrough in the treatment of anaemia caused by chronic kidney disease, as it offers a more convenient and easily accessible treatment option for patients who previously had to rely on injectable erythropoietin drugs.

In November 2022, the UK's National Health Service made a ground-breaking achievement by performing the first-ever transfusion of lab-grown RBCs grown from the donor cells. This scientific milestone could open up new avenues for treating people with the rare blood types.

Erythropoietin Drugs Market Report Highlights

The biologics segment dominates the market, accounting for a significant share of revenue, with popular products including Procrit, NeoRecormon, Epogin, Mircera, Aranesp, and Epogen.

The erythropoietin segment holds the largest market share in 2022. Epoetin-beta is expected to grow positively in the future due to its superiority in maintaining hemoglobin concentration in hemodialysis patients over Epoetin-alfa.

The renal diseases segment holds the largest share of the market In 2022, due to developed reimbursement policies for renal transplants and related diseases are also driving this segment.

North America dominated the market and is expected to grow at a highest CAGR over the projected period because of the presence of organizations advancing drug development, Medicare coverage for CKD patients, and FDA approval of drugs like Epogen, Aranesp, and Procrit.

The global players include: Amgen, Johnson & Johnson, Roche, Pfizer, Biocon, and Teva Pharmaceutical.

Polaris Market Research has segmented the Erythropoietin Drugs market report based on type, product, application and region:

Erythropoietin Drugs, Type Outlook (Revenue, USD Billion, 2019 - 2032)

  • Biologics
  • Biosimilars

Erythropoietin Drugs, Product Outlook (Revenue, USD Billion, 2019 - 2032)

  • Erythropoietin
  • Darbepoetin-alfa

Erythropoietin Drugs, Application Outlook (Revenue, USD Billion, 2019 - 2032)

  • Cancer
  • Renal Diseases
  • Neurology
  • Others

Erythropoietin Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Erythropoietin Drugs Market Insights

  • 4.1. Erythropoietin Drugs Market - Product Snapshot
  • 4.2. Erythropoietin Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of chronic diseases
      • 4.2.1.2. Off-label use of Erythropoiesis stimulating agents (ESAs)
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Patent expiration of branded drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Erythropoietin Drugs Market Product Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Erythropoietin Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Biologics
    • 5.3.1. Global Erythropoietin Drugs Market, by Biologics, by Region, 2019-2032 (USD Billion)
  • 5.4. Biosimilars
    • 5.4.1. Global Erythropoietin Drugs Market, by Biosimilars, by Region, 2019-2032 (USD Billion)

6. Global Erythropoietin Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Cancer
    • 6.3.1. Global Erythropoietin Drugs Market, by Cancer, by Region, 2019-2032 (USD Billion)
  • 6.4. Renal Diseases
    • 6.4.1. Global Erythropoietin Drugs Market, by Renal Diseases, by Region, 2019-2032 (USD Billion)
  • 6.5. Neurology
    • 6.5.1. Global Erythropoietin Drugs Market, by Neurology, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Erythropoietin Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Erythropoietin Drugs Market, by Product

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
  • 7.3. Erythropoietin
    • 7.3.1. Global Erythropoietin Drugs Market, by Erythropoietin, By Region, 2019-2032 (USD Billion)
  • 7.4. Darbepoetin-alfa
    • 7.4.1. Global Erythropoietin Drugs Market, by Darbepoetin-alfa, By Region, 2019-2032 (USD Billion)

8. Global Erythropoietin Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Erythropoietin Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Erythropoietin Drugs Market - North America
    • 8.3.1. North America: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
    • 8.3.3. North America: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Erythropoietin Drugs Market - U.S.
      • 8.3.4.1. U.S.: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Erythropoietin Drugs Market - Canada
      • 8.3.5.1. Canada: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Erythropoietin Drugs Market - Europe
    • 8.4.1. Europe: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Erythropoietin Drugs Market - UK
      • 8.4.4.1. UK: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Erythropoietin Drugs Market - France
      • 8.4.5.1. France: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Erythropoietin Drugs Market - Germany
      • 8.4.6.1. Germany: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Erythropoietin Drugs Market - Italy
      • 8.4.7.1. Italy: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Erythropoietin Drugs Market - Spain
      • 8.4.8.1. Spain: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Erythropoietin Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Erythropoietin Drugs Market - Russia
      • 8.4.10.1. Russia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Erythropoietin Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Erythropoietin Drugs Market - China
      • 8.5.4.1. China: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Erythropoietin Drugs Market - India
      • 8.5.5.1. India: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Erythropoietin Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Erythropoietin Drugs Market - Japan
      • 8.5.7.1. Japan: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Erythropoietin Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Erythropoietin Drugs Market - South Korea
      • 8.5.9.1. South Korea: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Erythropoietin Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Erythropoietin Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Erythropoietin Drugs Market - UAE
      • 8.6.5.1. UAE: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Erythropoietin Drugs Market - Israel
      • 8.6.6.1. Israel: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Erythropoietin Drugs Market - South Africa
      • 8.6.7.1. South Africa: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Erythropoietin Drugs Market - Latin America
    • 8.7.1. Latin America: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Erythropoietin Drugs Market - Mexico
      • 8.7.4.1. Mexico: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Erythropoietin Drugs Market - Brazil
      • 8.7.5.1. Brazil: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Erythropoietin Drugs Market - Argentina
      • 8.7.6.1. Argentina: Erythropoietin Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Erythropoietin Drugs Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Erythropoietin Drugs Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amgen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Johnson & Johnson
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Roche Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Pfizer
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Biocon
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Teva Pharmaceutical
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Kyowa Kirin
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. LG Life Sciences
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. AstraZeneca
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Intas Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Shire
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Boehringer Ingelheim
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Baxter International Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development